The FDA has even accepted a drug designed with cannabidiol for that goal (Epidiolex). Although the company only recommends it for two uncommon types of childhood epilepsy named Lennox-Gastaut syndrome and Dravet syndrome. In 2024, the U.S. Drug Enforcement Administration (DEA) indicated that they plan to reclassify cannabis as a https://devincmuah.smblogsites.com/35127769/not-known-facts-about-psychoactive-cannabinoids